162 related articles for article (PubMed ID: 58200)
41. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
[TBL] [Abstract][Full Text] [Related]
42. The effect of lisuride hydrogen maleate in the hyperprolactinaemia-amenorrhoea syndrome: clinical and hormonal responses.
De Cecco L; Foglia G; Ragni N; Rossato P; Venturini PL
Clin Endocrinol (Oxf); 1978 Dec; 9(6):491-8. PubMed ID: 106990
[TBL] [Abstract][Full Text] [Related]
43. Failure of bromocriptine to restore the menstrual cycle in normoprolactinemic post-pill amenorrhea.
Coelingh Bennink HJ; van der Steeg HJ
Fertil Steril; 1983 Feb; 39(2):238-40. PubMed ID: 6822306
[TBL] [Abstract][Full Text] [Related]
44. [Bromocryptin in obstetrics and gynecology].
Alipov VI; Beskrovnaia NI
Akush Ginekol (Mosk); 1980 Jul; (7):3-6. PubMed ID: 6998309
[No Abstract] [Full Text] [Related]
45. Letter: Bromocriptine and secondary amenorrhoea.
Seppălă M; Hirvonen E; Ranta T
Lancet; 1976 Jul; 2(7979):262. PubMed ID: 59281
[No Abstract] [Full Text] [Related]
46. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
[TBL] [Abstract][Full Text] [Related]
47. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
48. The efficacy of lisuride in the treatment of hyperprolactinemic amenorrhea.
Rojanasakul A; Sirimongkolkasem R; Chailurkit LO
J Med Assoc Thai; 1990 Feb; 73 Suppl 1():42-6. PubMed ID: 2351912
[TBL] [Abstract][Full Text] [Related]
49. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
[TBL] [Abstract][Full Text] [Related]
50. [Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].
Hiroi M; Kawakoshi S; Kaneko N
Horumon To Rinsho; 1983 Jan; 31(1):95-9. PubMed ID: 6682727
[No Abstract] [Full Text] [Related]
51. Outcome of treatment with bromocriptine in patients with hyperprolactinaemia.
al-Suleiman SA; Najashi S; Rahman J; Rahman MS
Aust N Z J Obstet Gynaecol; 1989 May; 29(2):176-9. PubMed ID: 2803131
[TBL] [Abstract][Full Text] [Related]
52. Raised serum PRL and androgen levels associated with hyrsutism, amenorrhoea and galactorrhoea.
Malato M
Acta Eur Fertil; 1978 Dec; 9(4):175-83. PubMed ID: 573041
[TBL] [Abstract][Full Text] [Related]
53. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
Rains CP; Bryson HM; Fitton A
Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
[TBL] [Abstract][Full Text] [Related]
54. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.
Barreca P; Giannola C; Palisi F
Acta Eur Fertil; 1978 Mar; 9(1):21-9. PubMed ID: 567920
[No Abstract] [Full Text] [Related]
55. Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea.
Crosignani PG; Reschini E; Lombroso GC; Arosio M; Peracchi M
Br J Obstet Gynaecol; 1978 Oct; 85(10):773-5. PubMed ID: 361068
[TBL] [Abstract][Full Text] [Related]
56. Hyperprolactinaemic amenorrhoea--results of treatment with bromocriptine.
Bergh T; Nillius SJ; Wide L
Acta Endocrinol Suppl (Copenh); 1978; 216():147-64. PubMed ID: 347859
[No Abstract] [Full Text] [Related]
57. [Experience obtained from prolactin-inhibiting therapy for functional sterility (author's transl)].
Gazárek F; Zenisek L; Talas M; Stehliková J; Fingerová H
Zentralbl Gynakol; 1980; 102(20):1145-7. PubMed ID: 7211013
[TBL] [Abstract][Full Text] [Related]
58. [Results of the long-term use of parlodel in different forms of lactorrhea].
Mel'nichenko GA; Pishulin AA; Gitel' EG; Nazarenko VA
Sov Med; 1984; (1):59-64. PubMed ID: 6701657
[No Abstract] [Full Text] [Related]
59. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
[No Abstract] [Full Text] [Related]
60. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
Sas M; Godó G; Morvay J
Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
